Cargando…
A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews
INTRODUCTION: There are few studies assessing how data on adverse drug events from consumers on social media compare with other sources. AIM: The aim of this study was to assess the consistency of adverse event data of statin medications from social media as compared with other sources. METHODS: We...
Autores principales: | Golder, Su, Smith, Karen, O’Connor, Karen, Gross, Robert, Hennessy, Sean, Gonzalez-Hernandez, Graciela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847442/ https://www.ncbi.nlm.nih.gov/pubmed/33001380 http://dx.doi.org/10.1007/s40264-020-00998-1 |
Ejemplares similares
-
Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media
por: Golder, Su, et al.
Publicado: (2022) -
Assessment of Beliefs and Attitudes About Statins Posted on Twitter: A Qualitative Study
por: Golder, Su, et al.
Publicado: (2020) -
The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review
por: Golder, Su, et al.
Publicado: (2023) -
Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab
por: Smith, Karen, et al.
Publicado: (2018) -
Active neural networks to detect mentions of changes to medication treatment in social media
por: Weissenbacher, Davy, et al.
Publicado: (2021)